Professional Documents
Culture Documents
11.0a ASC Full Specs MNL
11.0a ASC Full Specs MNL
The notes in the tables below are organized to follow the Table of Contents in the Specifications Manual.
Impacts: ASC-13
Rationale: Recently published systematic review supports the measure as currently specified. Minor
grammatical changes help to improve interpretation of measure guidance and add new reference.
Description of Change:
Description
Change from: This measure is used to assess the percentage of patients having surgical procedures under
general or neuraxial anesthesia of 60 minutes or more in duration are normothermic within 15 minutes of
arrival in PACU.
Change to: This measure is used to assess the percentage of patients having surgical procedures under
general or neuraxial anesthesia of 60 minutes or more in duration who are normothermic within 15 minutes
of arrival in PACU.
Data Element Definitions
Measure ascertains response to the following question:
Change from: What is the percentage of having surgical procedures under general or neuraxial anesthesia of
60 minutes or more in duration are normothermic within 15 minutes of arrival in PACU?
Change to: What is the percentage of patients having surgical procedures under general or neuraxial
anesthesia of 60 minutes or more in duration who are normothermic within 15 minutes of arrival in PACU?
References
Add new reference citation.
_______________________________________________________________________________________
Impacts: ASC-17
Rationale: Revised instructions to note that stakeholder inquiries need to be sent via ServiceNow.
Description of Change:
Introduction
Change from: Questions and comments about the measure should be directed to ascmeasures@yale.edu.
Change to: Please submit questions about the measure to the QualityNet Question and Answer Tool:
https://cmsqualitysupport.servicenowservices.com/qnet_qa.
Rationale: Minor edits to language to accommodate for the impact on performance periods due to CMS
COVID-19 Data Waiver.
Description of Change:
Included Populations
Change from: The target population is Medicare FFS patients aged 65 years and older undergoing
outpatient orthopedic surgeries at ASCs who have been enrolled in Part A and Part B Medicare for the
months prior to the date of surgery to ensure adequate data for identifying comorbidities for risk adjustment.
Change to: The target population is Medicare FFS patients aged 65 years and older undergoing outpatient
orthopedic surgeries at ASCs who have been enrolled in Part A and Part B Medicare for up to 12 months
prior to the date of surgery to ensure the availability of data for identifying comorbidities for risk adjustment.
Rationale: Update the directions for locating procedure codes in the measure cohort.
Description of Change:
Included Populations
Change from: For a list of procedure codes included in the measure cohort, see: Qualitynet.org >
Ambulatory Surgical Centers > Measures> Orthopedic Measure Dry Run > Measure Methodology.
Change to: For a list of procedure codes included in the measure cohort, see: https://qualitynet.cms.gov/ >
Ambulatory Surgical Centers > Measures> Orthopedic Measure > Methodology.
Rationale: Remove reference to ICD-9 CM.
Description of Change:
Risk Adjustment
Remove: All references to ICD-9 CM within the Measure Information Form.
_______________________________________________________________________________________
Impacts: ASC-18
Rationale: Update the directions for locating procedure codes in the measure cohort.
Description of Change:
Included Populations
Change from: The target population is Medicare FFS patients aged 65 years and older undergoing
outpatient orthopedic surgeries at ASCs who have been enrolled in Part A and Part B Medicare for the
months prior to the date of surgery to ensure adequate data for identifying comorbidities for risk adjustment.
Change to: The target population is Medicare FFS patients aged 65 years and older undergoing outpatient
orthopedic surgeries at ASCs who have been enrolled in Part A and Part B Medicare for up to 12 months
prior to the date of surgery to ensure the availability of data for identifying comorbidities for risk adjustment.
Rationale: Updating Table 1 for Risk adjustment variables to reflect additional patient-level variables for
ASC-18 Urology measure.
Description of Change:
Risk Adjustment Table 1
Add: “Number of qualifying procedures” in patient-level variable column and “Defined as 2 vs 1, 3, or
more vs. 1” in the Risk-adjusted variables column.
Add: “Surgical Procedural Complexity” in the patient-level variable column and “Work RVU” in the
Risk-adjusted variables column.
_______________________________________________________________________________________
Impacts: ASC-19
Rationale: New ASC-19 General Surgery measure information form added for Calendar Year 2024 payment
determination and subsequent years.
Description of Change:
Add: ASC-19 Measure Information Form.
_______________________________________________________________________________________
Impacts: ASC-9, ASC-11, ASC-13, and ASC-14
Rationale: Update the Web-based measure submission language to current Hospital Quality Reporting
(HQR) submission platform.
Description of Change:
The notes in the tables below are organized to follow the Table of Contents in the Specifications Manual.
Version 11.0a
Encounter Dates: 01-01-22 (1Q22) through 12-31-22 (4Q22)
Acknowledgement
The Ambulatory Surgical Center Quality Reporting Specifications Manual was developed by the Centers
for Medicare & Medicaid Services (CMS) to provide a uniform set of quality measures for the ambulatory
surgical center (ASC) setting. The primary purpose of these measures is to promote high quality care for
patients receiving services in ASC settings.
No royalty or user fee is required for copying or reprinting this manual, but there are conditions required
for use: 1) The copier or printer must disclose that the Ambulatory Surgical Center Quality Reporting
Specifications Manual is periodically updated and the copied or reprinted version may not be current, unless
the copier or printer has verified and affirmed the version is current. 2) The copier or printer must disclose
that users participating in the Ambulatory Surgical Center Quality Reporting (ASCQR) Program are required
to update their software and associated documentation based on the published Ambulatory Surgical Center
Quality Reporting Specifications Manual production quality timelines.
Example Acknowledgement: The Ambulatory Surgical Center Quality Reporting Specifications Manual
[Version xx, Month, Year] is periodically updated by the Centers for Medicare & Medicaid Services. Users
of the Ambulatory Surgical Center Quality Reporting Specifications Manual must update their software and
associated documentation based on the published manual production timelines.
CPT® only copyright 2021 American Medical Association. All rights reserved.
Fee Schedules, relative value units, conversion factors and/or related components are not assigned by the
American Medical Association (AMA), are not part of CPT®, and the AMA is not recommending their use.
The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes
no liability for data contained or not contained herein.
The International Classification of Diseases, 11th Revision, Clinical Modification (ICD-10-CM) is published
by the United States Government. A CD-ROM, which may be purchased through the Government Printing
Office, is the only official Federal government version of the ICD-10-CM. ICD-10-CM is an official Health
Insurance Portability and Accountability Act standard.
To submit Ambulatory Surgical Center Quality Reporting (ASCQR) Program measures to CMS, files
must meet the specifications found only in this CMS manual. Otherwise, the files will be rejected for
not meeting CMS quality data submission requirements and may not receive the full payment update.
Ambulatory Surgical Centers, then select Data Submission from the banner options. Click the Deadlines tile
from the left side of the page. Data will be completed through the Hospital Quality Reporting (HQR) Secure
Portal at https://hqr.cms.gov via an online tool available to authorized users.
]
Additional Instructions: Patients will be counted in the numerator if there is reference in the final
colonoscopy report that the appropriate follow-up interval for the repeat colonoscopy is at least 10 years
from the date of the current colonoscopy (i.e., the colonoscopy performed during the measurement period). A
range that includes “10 years” (e.g., 7 to 10 years) is not acceptable.
66987, 66988 ]
Excluded Population: Patients who did not complete both a pre-operative and post-operative survey.
Annual Data Submission Period: See the timeline posted to QualityNet.CMS.gov for this measure.
[
Select Ambulatory Surgical Centers then Data Submission from the banner options. Click the Deadlines
tile from the left side of the page. Data will be completed through the Hospital Quality Reporting (HQR)
Secure Portal at https://hqr.cms.gov via an online tool available to authorized users.
]
Data Collection Approach: Include procedures performed from the beginning of the reporting year through
90 days prior to the end of the reporting period. This will allow the post-operative period to occur.
Additional Instructions: Definition for Survey: An appropriate data collection instrument is an assessment
tool that has been validated for the population for which it is being used; this measure utilizes a visual
function survey. While it is recommended that the facility obtain the survey results from the appropriate
physician or optometrist, the surveys can be administered by the facility via phone, mail, email, or during
clinician follow-up. For this measure, the same data collection instrument (i.e., survey) must be used pre-
operatively and post-operatively.
Examples of tools for visual function assessment include, but are not limited to, National Eye Institute Visual
Function Questionnaire (NEI-VFQ) (http://www.rand.org/health/surveys_tools/vfq.html), the Visual
Function (VF)-14, the modified VF-8, the Activities of Daily Vision Scale (ADVS), the Catquest, and the
modified Catquest-9. For each of the VF tools (VF-14 or VF-8R), all questions have equal weight; only
non-missing questions are included, and the total weight is 100.
Definition of Performance Met: Improvement in visual function achieved within 90 days following
cataract surgery (G0913).
began calculating the measure with three years of claims data. For payment determination year 2024, the
performance period is July 2020 through December 2022. The performance period has been shortened to
exclude data for services occurring from January – June 2020 in accordance with the CMS COVID-19
Data Waiver.]
This measure was developed by a team of clinical and statistical experts from the Yale New Haven Health
Services Corporation/Center for Outcomes Research and Evaluation (YNHHSC/CORE), under contract to
CMS. The measure is currently endorsed by the National Quality Forum (NQF #2539).
The aim of the MIF is to provide transparency of the measure methodology to the facility and vendor
communities. Additional background information about the measure methodology can be found in the
Measure Updates and Specifications Report available on the Measure Methodology QualityNet page
(https://qualitynet.cms.gov/asc/measures/colonoscopy/methodology). CMS provides a new report each year
[ ]
to align with the most current calendar year. For example, the 2018 Measure Updates and Specifications
Report aligned with a performance period ending in calendar year 2018. If the reevaluation report associated
[ ]
with the performance period of this MIF is not yet available, it is sufficient to use the most recent report.
Please submit questions about the measure to the QualityNet Question and Answer Tool:
https://cmsqualitysupport.servicenowservices.com/qnet_qa
CMS calculates a facility-level, risk-standardized unplanned hospital visit rate for all eligible facilities.
Facilities and their ORYX® Vendors do not have sufficient data to produce facilities’ risk-standardized
results. CMS inpatient and outpatient claims data are used to determine whether a beneficiary has had an
unplanned hospital visit to any acute care hospital within 7 days of the outpatient colonoscopy. In addition,
CMS extracts and utilizes physician office, inpatient, and outpatient claims data from the year prior to the
colonoscopy, as well as claims data from the colonoscopy, to risk adjust the facility-level outcome rates.
to 12 months prior to the date of procedure to ensure the availability of administrative data for risk
] [ ]
adjustment.
The measure is focused on low-risk colonoscopies. Cohort codes are located in the data dictionary that
accompanies the Measure Updates and Specifications Report, available on the Measure Methodology
QualityNet page: https://qualitynet.cms.gov/asc/measures/colonoscopy/methodology (In prior years, all
[ ]
measure codes are located within the Measure Updates and Specifications Reports.)
Risk Adjustment:
The measure’s approach to risk adjustment is tailored to, and appropriate for, a publicly reported outcome
measure, as articulated in published scientific guidelines (Krumholz et al., 2006; Normand et al., 2007).
The measure uses a two-level hierarchical logistic regression model to estimate facility-level risk-
standardized hospital visit rates. This approach accounts for the clustering of patients within facilities
and variation in sample size across facilities.
The risk-adjustment model includes 15 patient-level variables (age, concomitant upper GI endoscopy,
polypectomy during the procedure, and 12 comorbidity variables). The measure defines comorbidity
variables using condition categories (CCs), which are clinically meaningful groupings of the many thousands
of International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis
codes. Certain CCs are considered possible complications of care; therefore, the measure does not risk-adjust
for them if they occur only at the time of the procedure. This is because only comorbidities that convey
information about the patient at the time of the procedure or in the 12 months prior, and not complications
that arose during the colonoscopy procedure, are included in the risk adjustment. The Measure Updates and
Specifications Report data dictionary contains complete definitions of risk factors and CCs that are
considered possible complications of care and are not risk adjusted for if they occur only at the time of
the procedure.
of arrival in PACU.
Numerator: Surgery patients with a body temperature equal to or greater than 96.8 Fahrenheit/36 Celsius
recorded within fifteen minutes of arrival in PACU.
Denominator: All patients, regardless of age, undergoing surgical procedures under general or neuraxial
anesthesia of greater than or equal to 60 minutes duration.
Numerator Exclusions: None
Denominator Exclusions: Patients who did not have general or neuraxial anesthesia; patients whose length
of anesthesia was less than 60 minutes; patients with physician/advance practice nurse/physician’s assistant
documentation of intentional hypothermia for the procedure performed.
Data Sources: ASC medical records, as well as anesthesia administration and nursing records, may
serve as data sources. Clinical logs designed to capture information relevant to normothermia are also
potential sources.
Data Element Definitions:
Anesthesia duration: The difference, in minutes, between the time associated with the start of anesthesia
for the principal procedure and the time associated with the end of anesthesia for the principal procedure.
Arrival in PACU: Time of patient arrival in PACU (post-anesthesia care unit)*.
General anesthesia: Drug-induced loss of consciousness during which the patient is not arousable,
even by painful stimulation.
Intentional hypothermia: A deliberate, documented effort to lower the patient's body temperature in the
perioperative period.
Neuraxial anesthesia: Epidural or spinal anesthesia.
Temperature: A measure in either Fahrenheit or Celsius of the warmth of a patient's body. Axillary, bladder,
core, esophageal, oral, rectal, skin surface, temporal artery, or tympanic temperature measurements may
be used.
Rationale: Impairment of thermoregulatory control due to anesthesia may result in perioperative
hypothermia. Hypothermia, even when mild, is associated with consequences such as increased susceptibility
to infection, impaired coagulation, cardiovascular stress, and cardiac complications, as well as post-
anesthetic shivering and thermal discomfort. Several methods to maintain normothermia are available.
There is no literature available on variation in rates of normothermia among ASC providers. However,
variability in maintaining normothermia has been demonstrated in other settings.
* Definition of Arrival in PACU is consistent with the definition in the Procedural Times Glossary of the
American Association of Clinical Directors as approved by the ASA, ACS and AORN.
procedures under general or neuraxial anesthesia of 60 minutes or more in duration who are normothermic
[ ]
Ambulatory Surgical Centers then Data Submission from the banner options, then click the Deadlines tile
from the left side of the page. Data will be completed through the Hospital Quality Reporting (HQR) Secure
Portal at https://hqr.cms.gov via an online tool available to authorized users.
]
References
American Society of PeriAnesthesia Nurses (ASPAN). ASPAN’s evidence-based clinical practice guideline
for the promotion of perioperative normothermia: second edition. J Perianesth Nurs. 2010;25(6):346–65.
Anderson DJ et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect
Control Hosp Epidemiol. 2014;35 Suppl 2: S66–88.
Balki I et al. Effect of perioperative active body surface warming systems on analgesic and clinical
[
outcomes: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg. 2020
Nov;131(5):1430-1443. ]
Berrios-Torres SI et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical
Site Infection, 2017. JAMA Surg. 2017 Aug 1;152(8):784–791.
Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB,
Kasper EK, Kersten JR, Riegel B, Robb JF. ACC/AHA 2007 guidelines on perioperative cardiovascular
evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on
Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2007;50: e159–241.
Frank SM, Fleisher LA, Breslow MJ, et al. Perioperative maintenance of normothermia reduces the
incidence of morbid cardiac events. A randomized clinical trial. JAMA. 1997;277(14): 1127–1134.
Frank SM, Beattie C, Christopherson R, et al. Unintentional hypothermia is associated with postoperative
myocardial ischemia. The Perioperative Ischemia Randomized Anesthesia Trial Study Group.
Anesthesiology. 1993;78(3):468–476.
Kurz A. Physiology of thermoregulation. Best Pract Res Clin Anaesthesiol. 2008;22(4):627–644.
Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound
infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med.
1996;334(19):1209- The quality measures presented in this guide are the intellectual property of the ASC
Quality Collaboration. 14 1215.
Kurz A, Sessler DI, Schroeder M, Kurz M. Thermoregulatory response thresholds during spinal anesthesia.
Anesth Analg. 1993;77(4):721-726.
Lista F, Doherty CD, Backstein RM, Ahmad J. The impact of perioperative warming in an outpatient
aesthetic surgery setting. Aesthet Surg J. 2012 Jul;32(5):613–20.
Matsukawa T, Sessler DI, Sessler AM, et al. Heat flow and distribution during induction of general
anesthesia. Anesthesiology. 1995;82(3):662–673.
Ambulatory Surgical Centers then Data Submission from the banner options. Click the Deadlines tile from
the left side of the page. Data will be completed through the Hospital Quality Reporting (HQR) Secure Portal
at https://hqr.cms.gov via an online tool available to authorized users.
]
References:
American Academy of Ophthalmology Cataract and Anterior Segment Panel. Preferred Practice Pattern®
Guidelines. Cataract in the Adult Eye. San Francisco, CA: American Academy of Ophthalmology; 2011.
date of surgery to ensure the availability of data for identifying comorbidities for risk adjustment.
[ ]
The measure includes procedures that are routinely performed at ASCs, involve increased risk of post-
surgery hospital visits, and are routinely performed by orthopedists. For a list of procedure codes included in
the measure cohort, see: https://qualitynet.cms.gov > Ambulatory Surgical Centers > Measures > Orthopedic
[
Exclusion:
1. Surgeries for patients who survived at least 7 days but were not continuously enrolled in Medicare FFS
Parts A and B in the 7 days after the surgery. The measure excludes these patients to ensure all patients
have full data available for outcome assessment.
Methodology.
Data Collection Approach: Medicare administrative claims and enrollment data
Data Accuracy: The administrative claims data used to calculate the measure are maintained by CMS’
Office of Information Services. These data undergo additional quality assurance checks during measure
development and maintenance.
Measure Analysis Suggestions: None
Sampling: No
Data Reported As: ASC-level 7-day risk-standardized, all-cause, unplanned hospital visit rate following
orthopedic surgery
Measure Calculation:
The measure estimates facility-level 7-day risk-standardized unplanned hospital visit rates using hierarchical
logistic regression modeling (a form of hierarchical generalized linear modeling [HGLM]). In brief, the
approach simultaneously models two levels (patient and facility) to account for the variance in patient
outcomes within and between facilities. At the patient level, the model adjusts the log-odds of a hospital visit
within 7 days of the surgery for age, procedural factors, and selected clinical covariates. At the facility level,
it estimates the facility-specific intercepts as arising from a normal distribution. The facility intercept
represents the underlying risk of a hospital visit within 7 days after an orthopedic surgery at an ASC while
accounting for patient risk. The facility-specific intercepts also account for the clustering (non-independence)
of patients within the same facility. If there were no differences among facilities, then after adjusting for
patient risk the facility-specific intercepts would be identical across all facilities.
date of surgery to ensure the availability of data for identifying comorbidities for risk adjustment.
[ ]
The measure includes surgeries that are routinely performed at ASCs, involve increased risk of post-surgery
hospital visits, and are routinely performed by urologists. For a list of procedure codes included in the
measure cohort, see: https://qualitynet.cms.gov/ > Ambulatory Surgical Centers > Measures > Urology
[
Exclusion:
1. Surgeries for patients who survived at least 7 days but were not continuously enrolled in Medicare FFS
Parts A and B in the 7 days after the surgery. The measure excludes these patients to ensure all patients
have full data available for outcome assessment.
Risk Adjustment:
The measure’s approach to risk adjustment is tailored to, and appropriate for, a publicly reported outcome
measure as articulated in published scientific guidelines (Krumholz et al., 2006; Normand et al., 2007).
The measure uses a two-level hierarchical logistic regression model to estimate facility-level risk-
standardized hospital visit rates. This approach accounts for the clustering of patients within facilities and
variation in sample size across facilities.
The measure adjusts for differences across facilities in patient demographics, clinical factors, and surgery-
related risk. Potential candidate risk factors were identified from related quality measures and the literature; a
preliminary list of risk factors was developed and then revised based on a Technical Expert Panel (TEP) and
expert clinical input.
The risk-adjustment model has 7 patient-level variables (age and 6 comorbidity variables), number of
qualifying procedures, and work relative value units (RVU) to adjust for surgical complexity (see Table 1).
With the exception of benign prostatic hyperplasia with obstruction which we define using an individual
ICD-10-CM diagnosis code, we define comorbidity variables using CMS Condition Categories (CCs), which
are clinically meaningful groupings of many thousands of ICD-10-CM diagnosis codes.
Table 1: Patient-Level Risk-Adjustment Variables
Patient-level variables Risk-adjusted variables
Demographics Age (years greater than 65)
Benign prostatic hyperplasia with obstruction
Complications of specified implanted device or graft
Poisonings and inflammatory allergic reactions
Comorbidities
Major symptoms, abnormalities
Parkinson's and Huntington's diseases; seizure disorders and convulsions
Ischemic heart disease
Number of Qualifying
[ Defined as 2 vs. 1, 3, or more vs. 1
[ ]
Procedures ]
Surgical Procedural
[ Work RVU
[ ]
Complexity ]
Performance Measure Name: COVID-19 Vaccination Coverage Among Health Care Personnel (HCP
COVID-19 Vaccination)
Measure ID #: ASC-20
Description: For more information about the National Healthcare Safety Network (NHSN) measures, see
the resources located at http://www.cdc.gov/nhsn/.
Annual data submission period: See the timeline posted to QualityNet.cms.gov for this measure; select
Ambulatory Surgical Centers (ASC) then click the Learn More dial, then select Participation from the banner
options.
Direct questions regarding NHSN training, enrollment, and submission to: NHSN@cdc.gov.
Denominator: Number of HCP eligible to work in the ASC for at least 1 day during the self-selected week,
excluding persons with contraindications to COVID-19 vaccination.
Numerator: cumulative number of HCP eligible to work in at the ASC for at least 1 day during the self-
selected week and who received a complete vaccination course against COVID-19 using an FDA-authorized
or FDA-approved vaccine for COVID-19 (whether the FDA issued an approval or EUA).160 A complete
vaccination course is defined under the specific FDA authorization and may require multiple doses or regular
revaccination.
Numerator Statement: Patients who had a recommended follow-up interval of at least 10 years for repeat
colonoscopy documented in their colonoscopy report
Denominator Statement: All patients ≥ 50 to ≤ 75 years of age receiving screening colonoscopy without biopsy or
polypectomy
Documentation of medical
reason(s) for not
Patient aged ≥ 50 recommending at least a
N
to ≤ 75 years 10-year follow-up interval
(e.g., above average risk
patient or inadequate prep)
Biopsy or Follow-up
Y polypectomy interval
performed of at least
Documentation of a
10 years Y
recommended
follow-up interval
N
of at least 10 years N
for repeat N
colonoscopy
documented in the
colonoscopy report Follow-up Exclude from
Exclude from
interval the
the
of at least measure
numerator
10 years population
Exclude from
Include in the Include in the
the
numerator denominator End
measure
population population
population
Numerator Statement: Surgery patients with a body temperature equal to or greater than 96.8 Fahrenheit/36 Celsius
recorded within fifteen minutes of arrival in PACU
Denominator Statement: All patients, regardless of age, undergoing surgical procedures under general or neuraxial
anesthesia of greater than or equal to 60 minutes duration
Time
from Start Exclude from the
of anesthesia to End of N measure
anesthesia population
≥ 60 Minutes
Patient’s body
Exclude from the
temperature recorded
N measure
within 15 minutes
population
of PACU arrival
Recorded
body temperature ≥ 96.8°
Enter as Numerator Y
Fahrenheit or
36° Celsius
End
Adapted from algorithm provided by For use with encounter dates 010122-123122;
clinical services group/HCA; January 2020 Specifications Manual version 11.0a
A-40
ASC-13: Normothermia Outcome Example Questions
Step 1: Identify surgical patients with general or neuraxial (epidural or spinal) anesthesia equal
to or greater than 60 minutes in duration (Denominator).
• Did the patient have a general or neuraxial anesthetic?
o Cases with strictly sedation or local anesthesia would not be included.
• What was the Start time of anesthesia?
o If there is no Start time, do not include patient in the Denominator.
o If both Start time and Induction time are documented, use Start time.
o If there is no Start time but there is an Induction time, do not include patient
in the Denominator.
• What is the End time of anesthesia?
o If there is no End time, do NOT include patient in the Denominator.
o If there is no End time documented, do NOT include patient in the Denominator.
If the duration between Start time and End time is equal to or greater than 60 minutes, the patient
can be included in the Denominator.
Step 2: Determine how many patients in the Denominator population had the required body
temperature within 15 minutes of arriving in the PACU (Numerator).
If the patient had a body temperature greater than or equal to 96.8°F or 36°C 15 minutes after
arrival in the PACU, then the patient can be included in the Numerator.
Step 3: Determine if the number of cases meet the Sampling Specifications.
If the population is 0–900, a sample of 63 may be used: If the population is greater than or equal
to 901, a sample of at least 96 should be used. If the population is fewer than 63 cases, the total
population of cases is required.
Example: An ASC performed 903 surgical procedures. The number of procedures exceeds 901
and can be sampled using at least 96 cases.
Scenario 1
Medicare patient has surgical procedure using general anesthesia.
Start time of anesthesia was 0615.
End time of anesthesia was documented on the operating room (OR) form at 0720.
Patient’s arrival to PACU was documented at 0725.
Body temperature was 36°C at 0730.
Denominator criteria met? Yes
Numerator criteria met? Yes
The patient received general anesthesia for the duration of 65 minutes and had a
documented body temperature of 36°C within 15 minutes of arrival in the PACU.
This patient should be included in this measure.